Magnamed is a company specialized in respiratory care that growths more in Brazil. Whether in the ICU or Transportation and Emergency Line, its products are characterized by innovation, efficiency and quality.

Its mission is to help preserving lives, continually innovating in the area of critical care and developing equipment to facilitate the complex routine of its customers.

Magnamed is a Brazilian company focused on the critical care market specializing in pulmonary ventilation. The company stands out in the development of high-tech hospital medical equipment and intelligent innovation for life.

The company was founded in 2005 by three partners engineers, containing innovation in their DNA. Magnamed is recognized in more than 40 countries for its in-depth knowledge and constant search for new solutions for the market. With six medical devices in its portfolio - the Oxymag, Oxymag Agile Fleximag, FlexiMag Plus and Babymag lung ventilators, and the Ventmeter test analyzer. Between 2012 and 2014, the company registered a growth of 150%. In early 2015, the new Magnamed plant, located in the industrial district of Cotia, in the greater São Paulo, began operations. Magnamed is one of the investees of the Fund Criatec, co-managed by INSEED and held the first round in 2008.

The MAGNAMED is a Brazilian company focused on the critical care market specializing in pulmonary ventilation. The company stands out in the development of hospital medical equipment of high technology and intelligent innovation for life. The company was founded in 2005 by three engineers partners, containing innovation in its DNA. The MAGNAMED is recognized in over 40 countries, in -depth knowledge and the constant search for new solutions to the market.